ArticleFrontiers in neurology
Development and internal validation of a clinical prediction model for 1-year recurrence after first-ever ischemic stroke.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Ischemic stroke (IS) recurrence remains a major contributor to poor prognosis, particularly within the 1 year after the index event. This study aimed to develop and internally validate a clinical prediction model for estimating the risk of 1-year recurrence after first-ever IS using routinely available admission data. Methods: We conducted a retrospective cohort study including consecutive patients with first-ever IS admitted to a tertiary hospital in China between January and December 2021. The primary outcome was IS recurrence within 1 year after discharge. Missing predictor data were handled using multiple imputation by chained equations. A multivariable logistic regression model was developed in the full cohort using six predictors: National Institutes of Health Stroke Scale (NIHSS) score, age, admission systolic blood pressure, uric acid, apolipoprotein A1, and neutrophil percentage. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), bootstrap internal validation with 1,000 resamples, calibration intercept, calibration slope, Brier score, and decision curve analysis. Results: Among 738 eligible patients, 96 (13.0%) experienced IS recurrence within 1 year. Higher NIHSS score, older age, higher uric acid, and higher neutrophil percentage were associated with increased recurrence risk, whereas higher apolipoprotein A1 was associated with reduced risk. Admission systolic blood pressure showed a borderline association with recurrence risk. The model demonstrated moderate discrimination, with an apparent AUC of 0.764 (95% CI 0.710-0.819). Bootstrap internal validation yielded an optimism-corrected AUC of 0.750. The bootstrap-corrected calibration intercept, calibration slope, and Brier score were 0.0058, 0.9354, and 0.0981, respectively. Decision curve analysis showed greater net benefit than the treat-all and treat-none strategies across most threshold probabilities from 0.05 to 0.60. Conclusion: We developed and internally validated a six-predictor clinical prediction model for 1-year recurrence after first-ever IS using routinely available admission variables. The model showed moderate discrimination and acceptable calibration after bootstrap correction. It may serve as a preliminary tool for risk stratification, but external validation is required before routine clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.